CART T-Cell Therapy In Patients of Advanced Age Question Title * 1. I attended this web program as a: (select one). Patient Caregiver Family Member Friend/Concerned Individual Healthcare Professional Community Member LLS Staff LLS Volunteer Other (please specify) Question Title * 2. What is your race or ethnicity? Asian Black or African American Hispanic or Latino American Indian or Alaskan Native Native Hawaiian or other Pacific Islander White Prefer not to disclose Question Title * 3. Are you Hispanic/Latino/a/x? Yes No Question Title * 4. What is your date of birth? (LLS is unable to correspond with minors.) (MM/DD/YYYY) Date Question Title * 5. Do you describe yourself as a man, a woman, or in some other way? A Man A Woman Prefer not to answer In some other way (with open text field) Question Title * 6. In what ZIP/Postal code is your home located? Question Title * 7. Have you or the patient been diagnosed with a blood cancer? Yes No N/A If no, please tell us the type of cancer with which you/patient were diagnosed: Question Title * 8. If yes, when were you/patient diagnosed? (MM/DD/YYYY) Date Question Title * 9. If yes, please tell us what type of blood cancer (check all that apply): Non-Hodgkin lymphoma (NHL) Mantle cell lymphoma (MCL) Hodgkin lymphoma (HL) Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Myelodysplastic syndromes Myeloproliferative neoplasms (MPN) (polycythemia vera, essential thrombocythemia, myelofibrosis) Multiple myeloma Other (please specify) Question Title * 10. Are you or the patient currently being treated? Yes No Question Title * 11. What treatments have you or the patient had? (check all that apply): Combination drug therapy (chemotherapy) Single Drug Therapy Allogeneic stem cell transplant (donor) Autologous stem cell transplant CAR T- cell Therapy Radiation therapy Immunotherapy Blood transfusions Watch & Wait N/A Other (please specify) Question Title * 12. Are you presently in or have you ever participated in a clinical trial? Yes No N/A Question Title * 13. As a result of participating in this program, to what extent do you agree to the following statements? (Select one answer for each) Strongly Disagree Disagree Agree Strongly Agree N/A I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. Strongly Disagree I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. Disagree I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. Agree I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. Strongly Agree I am knowledgeable of which blood cancers benefit from CAR T-cell therapy. N/A I know when to discuss CAR T-cell therapy with my doctor. I know when to discuss CAR T-cell therapy with my doctor. Strongly Disagree I know when to discuss CAR T-cell therapy with my doctor. Disagree I know when to discuss CAR T-cell therapy with my doctor. Agree I know when to discuss CAR T-cell therapy with my doctor. Strongly Agree I know when to discuss CAR T-cell therapy with my doctor. N/A I know the factors to consider regarding CAR T-cell therapy for older adults . I know the factors to consider regarding CAR T-cell therapy for older adults . Strongly Disagree I know the factors to consider regarding CAR T-cell therapy for older adults . Disagree I know the factors to consider regarding CAR T-cell therapy for older adults . Agree I know the factors to consider regarding CAR T-cell therapy for older adults . Strongly Agree I know the factors to consider regarding CAR T-cell therapy for older adults . N/A I know the potential side effects of CAR T-cell therapy. I know the potential side effects of CAR T-cell therapy. Strongly Disagree I know the potential side effects of CAR T-cell therapy. Disagree I know the potential side effects of CAR T-cell therapy. Agree I know the potential side effects of CAR T-cell therapy. Strongly Agree I know the potential side effects of CAR T-cell therapy. N/A Question Title * 14. Following this program, do you feel more prepared to discuss CAR T-cell therapy with your healthcare team? Yes No N/A Question Title * 15. Which form(s) of cancer education do you most prefer? Webcasts (live or pre-recorded) Short videos Podcasts Booklets Other (please specify) Question Title * 16. Please describe any information you expected to get from this program but did not receive. Question Title * 17. Please give us any additional feedback about this program. Done